Eric W. Jacobson, Senior VP, Research and CMO at SYNTA PHARMACEUTICALS CORP (SNTA), bought 300 shares at $10.00 ($3K) on 2007-02-09, disclosed to the SEC on 2007-02-13.
Open-market purchase of $3k SNTA by Senior VP, Research and CMO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.